After BAY-299 treatment, the expression of caspase-1, caspase-4, GSDMB, GSDMC, GSDMD, and GSDME in AML cells increases, suggesting that BAY-299 treatment induces apoptosis and triggers pyroptosis. The gene discussed is CASP1; the disease is acute myeloid leukemia.